Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22012996 | 0.92 | L3MBTL1 (0.33) | L3MBTL1HPGDLMNAPOLBMAPK1 | |
| SCHEMBL22011933 | 0.92 | L3MBTL1 (0.33) | L3MBTL1HPGDLMNAPOLBMAPK1 | |
| SCHEMBL19986105 | 0.90 | ALDH1A1 (0.33) | L3MBTL1HPGDLMNAPOLBMAPK1 | |
| SCHEMBL17451711 | 0.90 | ALDH1A1 (0.33) | L3MBTL1HPGDLMNAPOLBMAPK1 | |
| SCHEMBL22011553 | 0.90 | HPGD (0.39) | L3MBTL1HPGDLMNAPOLBMAPK1 | |
| SCHEMBL22011452 | 0.90 | HPGD (0.40) | L3MBTL1HPGDLMNAPOLBMAPK1 | |
| SCHEMBL22011685 | 0.89 | L3MBTL1 (0.33) | L3MBTL1HPGDLMNAPOLBMAPK1 | |
| SCHEMBL22011686 | 0.88 | L3MBTL1 (0.31) | L3MBTL1HPGDLMNAPOLBMAPK1 | |
| SCHEMBL22011942 | 0.87 | L3MBTL1 (0.30) | L3MBTL1HPGDLMNAPOLBMAPK1 | |
| SCHEMBL22011940 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12035625-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2024-07-09 | — | — | US | disclosed |
| US-12035625-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2024-07-09 | — | — | US | disclosed |
| EP-3880682-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2023-06-14 | — | — | EP | disclosed |
| US-20220006030-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2022-01-06 | — | — | US | disclosed |
| WO-2020099307-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2020-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220006030-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | ZYX, RER1, AOC2 | L3MBTL1 2301/4885HPGD 3659/4885LMNA 1050/4885 |
| US-12035625-B2 | Materials for organic electroluminescent devices | ZYX, RER1, AOC2 | L3MBTL1 2301/4885HPGD 3659/4885LMNA 1050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.